Eric G. Meissner, Anita Kohli, Jeanette Higgins, Yu‐Jin Lee, Olga Prokunina, David Wu, Cody Orr, Henry Masur, Shyam Kottilil – 24 July 2017 – Treatment of chronic hepatitis C virus (HCV) infection with direct‐acting antivirals results in a rapid decline in viral load and markers of hepatic inflammation, including serum chemokine (C‐X‐C motif) ligand 10 (CXCL10) concentration, which is followed in most cases by a sustained virologic response. Whether parallel changes of significance occur in the cellular composition of peripheral blood is relatively unknown.

Stavra A. Xanthakos, Andrew T. Trout, Jonathan R. Dillman – 24 July 2017

Salvatore Petta, Luca Valenti, Antonino Tuttolomondo, Paola Dongiovanni, Rosaria Maria Pipitone, Calogero Cammà, Daniela Cabibi, Vito Di Marco, Anna Ludovica Fracanzani, Sara Badiali, Valerio Nobili, Silvia Fargion, Stefania Grimaudo, Antonio Craxì – 24 July 2017 – The interferon (IFN) lambda 3/4 (IFNL3/4) locus, influencing innate immunity regulation, has been associated with the severity of hepatitis and fibrosis progression during chronic hepatitis C infection, while contrasting results were reported in nonalcoholic fatty liver disease.

Michael Ronan Lucey – 24 July 2017

Puneeta Tandon, Karen Madsen, Dina Kao – 22 July 2017

Mehul H. Doshi, Jason Salsamendi, Govindarajan Narayanan – 22 July 2017

Ahmer M. Hameed, Jerome M. Laurence, Vincent W. T. Lam, Henry C. Pleass, Wayne J. Hawthorne – 22 July 2017 – The efficacy of cold in situ perfusion and static storage of the liver is a possible determinant of transplantation outcomes. The aim of this study was to determine whether there is evidence to substantiate a preference for a particular perfusion route (aortic or dual) or perfusion/preservation solution in donation after brain death (DBD) liver transplantation. The Embase, MEDLINE, and Cochrane databases were used (1980‐2017).

Seong Hoon Kim, Eung Chang Lee, Jae Ryong Shim, Sang Jae Park – 22 July 2017 – The evidence is insufficient for safe use of elderly donors in adult‐to‐adult living donor liver transplantation (LDLT). The aim of this study was to evaluate the outcomes of right lobe LDLT by donor age (≥55 versus < 55 years). All living donors who underwent right hepatectomy at the authors’ institution between March 2008 and December 2015 were divided into 2 groups: group A with an age ≥ 55 years and group B with an age of <55 years.

Tilman Sauerbruch – 22 July 2017

Jennifer C. Lai – 22 July 2017